Ratings by Leerink (Asthika Goonewardene)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/21/2026 | Whitehawk Therapeutics | WHWK | New Coverage | Outperform (N/A) |
3.79 (4.63) |
22.16% | Details | |
| 7/21/2026 | Molecular Partners | MOLN | New Coverage | Outperform (N/A) |
4.00 (4.29) |
7.25% | Details | |
| 7/21/2026 | Kura Oncology | KURA | New Coverage | Outperform (N/A) |
10.68 (12.89) |
20.69% | Details | |
| 7/21/2026 | Compass Therapeutics | CMPX | New Coverage | Outperform (N/A) |
2.02 (2.31) |
14.36% | Details | |
| 7/21/2026 | Aktis Oncology | AKTS | New Coverage | Outperform (N/A) |
23.96 (25.99) |
8.47% | Details |
